Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma. [electronic resource]
Producer: 20190503Description: 490-497 p. digitalISSN:- 1398-9995
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.